scispace - formally typeset
G

Gideon Koren

Researcher at Ariel University

Publications -  2007
Citations -  88165

Gideon Koren is an academic researcher from Ariel University. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 129, co-authored 1994 publications receiving 81718 citations. Previous affiliations of Gideon Koren include McGill University Health Centre & University of Western Ontario.

Papers
More filters
Journal ArticleDOI

Neurodevelopment of children exposed in utero to treatment of maternal malignancy.

TL;DR: The goal of this report was to summarize all related issues into one review to facilitate both practitioners’ and patients’ access to known data on fetal risks and safety.
Journal Article

Influenza vaccination during pregnancy.

TL;DR: No evidence indicates that killed influenza vaccine is teratogenic, even if given during the first trimester, and it is recommended that pregnant women in their second and third trimesters be vaccinated.
Journal ArticleDOI

Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL.

TL;DR: It is hypothesized that improper dissolution of the vehicle Cremophor EL may have been a cause for these anaphylactoid reactions during a phase I/II trial of high-dose intravenous cyclosporine (CsA) therapy to attenuate tumor multidrug resistance (MDR).
Journal Article

Safety and efficacy of blue cohosh (Caulophyllum thalictroides) during pregnancy and lactation.

TL;DR: Based on the available scientific information, blue cohosh should be used with extreme caution during pregnancy, be used only under medical professional supervision and not be available to the public as an over-the-counter product.
Journal ArticleDOI

The hypertensive disorders of pregnancy (29.3)

TL;DR: Progress is made in the use of out-of-office blood pressure measurement as an adjunct to officeBlood pressure measurement, pre-eclampsia defined as proteinuria or relevant end-organ dysfunction, antihypertensive therapy for severe and non-severe hypertension and post-partum follow-up to mitigate the increased cardiovascular risk associated with any of the hypertensive disorders of pregnancy.